Skip to main content
. 2015 Oct 9;90:99–105. doi: 10.1016/j.curtheres.2015.09.001

Table III.

Summary of adverse events (AEs) and adverse drug reactions (ADRs).

AE or ADR Safety data set (n = 410)
n (%)
All AEs 176 (42.9)
Severity of AE
 Mild 162 (39.5)
 Moderate 13 (3.2)
 Severe 1 (0.2)
≥1% of AEs
 Hyperuricemia 30 (7.3)
 Hyperlipidemia 23 (6.8)
 Dizziness 12 (2.9)
 Hepatic dysfunction 8 (2.0)
 Headache 4 (1.0)
All ADRs 40 (9.8)
≥0.7% of ADRs
 Dizziness 8 (2.0)
 Hyperuricemia 5 (1.2)
 Hepatic dysfunction 3 (0.7)
 Headache 3 (0.7)
 Fatigue 3 (0.7)